June 22, 2026
Nura Bio
Nura Bio is a developer of therapies for neurodegenerative conditions.
- Round
- Series B
- Amount raised
- $73.8M
- Lead investor
- The Column Group
- Industry
- Biotechnology
- Headquarters
- San Francisco, United States
- Employees
- —
- Website
- —
- —
Other investors
- Euclidean Capital
- Samsara BioCapital
- Sanofi Ventures
Source: Axios Pro Rata